Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
LSE:CREO
Price:
36.243 GBX
0.68%
Updated:
May 1, 2024
Creo Medical Group PLC
Cash from Investing Activities
|
Creo Medical Group PLC
Cash from Investing Activities Peer Comparison
Comparables:
SN
LIVN
LMDX
EKF
AGL
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Creo Medical Group PLC
LSE:CREO
|
Cash from Investing Activities
-£6m
|
CAGR 3-Years
-95%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Smith & Nephew PLC
LSE:SN
|
Cash from Investing Activities
-$448m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Cash from Investing Activities
-$40.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Cash from Investing Activities
-$25m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Cash from Investing Activities
-£5.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-10%
|
|
|
Angle PLC
LSE:AGL
|
Cash from Investing Activities
-£1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Creo Medical Group PLC's Cash from Investing Activities?
Cash from Investing Activities
-6m
GBP
-6m
GBP
Based on the financial report for Dec 31, 2022, Creo Medical Group PLC's Cash from Investing Activities amounts to -6m GBP.
What is Creo Medical Group PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-95%
-95%
Over the last year, the Cash from Investing Activities growth was 24%. The average annual Cash from Investing Activities growth rates for Creo Medical Group PLC have been -95% over the past three years .
You don't have any saved screeners yet
